Hoehn Daniela - Department of Pathology and Cell Biology, Columbia University Medical Center

基本信息

浏览量：25

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 69 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

IBCL-278 Epcoritamab with Rituximab + Lenalidomide (R2) in Previously Untreated (1L) Follicular Lymphoma (FL) and Epcoritamab Maintenance Therapy in FL: EPCORE NHL-2 Arms 6 and 7

Lorenzo Falchi,Joost S.P. Vermaat, Gerardo Musuraca, Marcel Nijland,Jacob Haaber Christensen, Fritz Offner, Lori A. Leslie,Joshua D. Brody,Daniela Hoehn,Jennifer Marek, Liwei Wang, Jian Mei, David Belada, Pau Abrisqueta

Clinical Lymphoma Myeloma and Leukemia (2024)

引用0浏览0引用

Epcoritamab SC + R-Mini-CHOP Leads to High Complete Metabolic Response Rates in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Ineligible for Full-Dose R-CHOP: First Disclosure from Arm 8 of the Epcore NHL-2 Trial

Joost S. P. Vermaat,Joshua Brody,Juraj Duras,Yasmin H. Karimi,Chan Y. Cheah,Justin M. Darrah,Gerardo Musuraca,Franck Morschhauser,Daniela Hoehn,Ali Rana,Yaou Song, Pegah Jafarinasabian,David Belada

Transplantation and Cellular Therapyno. 2 (2024)

引用0浏览0引用

Abstract 3732: Peripheral Pharmacodynamic Activity of Epcoritamab As Monotherapy and in Combination with Rituximab + Lenalidomide in Patients with Follicular Lymphoma

Han Si,Jimin Zhang,Monica Wielgos-Bonvallet,Lorenzo Falchi,Kim Linton,Wojciech Jurczak,David Belada,Isil Altintas,Mariana Sacchi,Elena Favaro,Ali Rana,Daniela Hoehn,David Soong,Christopher W. Chiu,Maria Jure-Kunkel

Cancer researchno. 6_Supplement (2024): 3732-3732

引用0浏览0引用

EPCORE FL-2: Phase 3 Trial of Epcoritamab with Rituximab and Lenalidomide (R2) Vs Chemoimmunotherapy or R2 in Previously Untreated Follicular Lymphoma

Kim M. Linton,Philip Thompson, Stefano Luminari,Carla Casulo,Poliana Patah, Lingmin Zeng, J. P. Mei, Neha Dixit,Daniela Hoehn, Emmanuel Bachy

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

EPCORE NHL-1 Follicular Lymphoma (FL) Cycle (C) 1 Optimization (OPT) Cohort: Expanding the Clinical Utility of Epcoritamab in Relapsed or Refractory (R/R) FL

Julie Vose,Umberto Vitolo,Pieternella Lugtenburg,Martine E. D. Chamuleau,Kim M. Linton, Catherine Thieblemont,Kristina Sonnevi,Wojciech Jurczak,Adam J. Olszewski,Farrukh Tauseef Awan, Craig Y. Okada,Tatyana A. Feldman,Martin Hutchings,Elena Favaro,Daniela Hoehn, Zhu Li,Rebekah Conlon,Juan-Manuel Sancho,Julio C. Chavez

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Abstract 5071: Minimal Residual Disease (MRD) Status by Peripheral Blood Mononuclear Cells (pbmcs) and Circulating Tumor DNA (ctdna) Demonstrates Rapid, Deep, and Sustained Response in Patients (pts) with Relapsed/refractory Follicular Lymphoma (R/R FL) Treated with Subcutaneous (SC) Epcoritamab Monotherapy in the Pivotal Phase ..

David Soong,Işıl Altıntaş, John Karavitis,Kim M. Linton,Wojciech Jurczak,Catherine Thieblemont, Kevin Zhao,Edith Szafer-Glusman,Daniela Hoehn,Elena Favaro,Mariana Sacchi,Maria Jure-Kunkel

Cancer Researchno. 6_Supplement (2024): 5071-5071

引用0浏览0引用

Epcoritamab with Rituximab Plus Lenalidomide (R2) in Previously Untreated (1L) Follicular Lymphoma (FL) and Epcoritamab Maintenance in FL: EPCORE NHL-2 Arms 6 and 7

Leslie A. Lori, Lorenzo Falchi,Joost S. P. Vermaat, Gerardo Musuraca,David Belada,Marcel Nijland,Jacob Haaber Christensen,Fritz Offner,Daniela Hoehn,Jennifer Marek,Liwei Wang, J. P. Mei, Pau Abrisqueta,Joshua D. Brody

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Intratumoral T-cell Composition Predicts Epcoritamab-Based Treatment Efficacy in B-cell Non-Hodgkin Lymphomas

Lorenzo Falchi,Jahan Rahman, Lauren Melendez, Monifa Douglas,Walter Ramos Amador,Paul Hamlin,Anita Kumar,Daniela Hoehn,Ya-Hui Lin,Qi Gao,Mikhail Roshal,Mark D Ewalt,Ahmet Dogan,Benjamin Greenbaum,Gilles A Salles,Santosha A Vardhana

medRxiv the preprint server for health sciences (2024)

引用0浏览0WOS引用

EPCORE FL-1: Phase 3 Trial of Subcutaneous Epcoritamab with Rituximab and Lenalidomide (R 2) Vs R 2 Alone in Patients with Relapsed or Refractory Follicular Lymphoma

Lorenzo Falchi,Franck Morschhauser,Kim Linton,Huiqiang Huang,Faith Galderisi,Syed Quadri, Lingmin Zeng,Daniela Hoehn,John F. Seymour

Bloodno. Supplement 1 (2023): 3053-3053

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn